Header Logo

Connection

ANTHONY LUCCI to Mastectomy

Back to Details
This is a "connection" page, showing publications ANTHONY LUCCI has written about Mastectomy.
ANTHONY LUCCI
Connection Strength
2.343
Mastectomy
  1. Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery. Ann Surg Oncol. 2017 Oct; 24(10):2981-2988.
    View in: PubMed
    Score: 0.367
  2. Prognostic Value of Circulating Tumor Cells Identified Before Surgical Resection in Nonmetastatic Breast Cancer Patients. J Am Coll Surg. 2016 07; 223(1):20-9.
    View in: PubMed
    Score: 0.333
  3. Oncoplastics: techniques for reconstruction of partial breast defects based on tumor location. J Surg Oncol. 2011 Mar 15; 103(4):341-7.
    View in: PubMed
    Score: 0.236
  4. Assessment of the current Medicare reimbursement system for breast cancer operations. Ann Surg Oncol. 2004 Dec; 11(12):1037-44.
    View in: PubMed
    Score: 0.152
  5. Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy. Ann Surg Oncol. 2023 Oct; 30(10):6232-6240.
    View in: PubMed
    Score: 0.139
  6. Mastectomy performed with scissors following tumescent solution injection. J Surg Oncol. 2003 Jul; 83(3):191-3.
    View in: PubMed
    Score: 0.138
  7. Current Surgical Management of Inflammatory Breast Cancer. Ann Surg Oncol. 2021 Oct; 28(10):5461-5467.
    View in: PubMed
    Score: 0.121
  8. The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Ann Surg Oncol. 2021 Aug; 28(8):4265-4274.
    View in: PubMed
    Score: 0.116
  9. Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery? Ann Surg Oncol. 2020 Nov; 27(12):4603-4612.
    View in: PubMed
    Score: 0.113
  10. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg. 2018 05; 267(5):946-951.
    View in: PubMed
    Score: 0.097
  11. Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted? Ann Surg Oncol. 2013 Dec; 20(13):4103-12.
    View in: PubMed
    Score: 0.070
  12. Reduced incidence of breast cancer-related lymphedema following mastectomy and breast reconstruction versus mastectomy alone. Plast Reconstr Surg. 2012 Dec; 130(6):1169-1178.
    View in: PubMed
    Score: 0.066
  13. Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy. Plast Reconstr Surg. 2011 May; 127(5):1763-1772.
    View in: PubMed
    Score: 0.059
  14. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application? Expert Rev Anticancer Ther. 2007 Oct; 7(10):1463-72.
    View in: PubMed
    Score: 0.046
  15. Surgical treatment of pregnancy associated breast cancer. Breast Dis. 2005-2006; 23:87-93.
    View in: PubMed
    Score: 0.038
  16. Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities. Ann Surg Oncol. 2024 Oct; 31(11):7326-7334.
    View in: PubMed
    Score: 0.037
  17. Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery. Ann Surg Oncol. 2024 Jun; 31(6):3649-3660.
    View in: PubMed
    Score: 0.036
  18. Contemporary surgical management of inflammatory breast cancer: a narrative review. Chin Clin Oncol. 2021 Dec; 10(6):57.
    View in: PubMed
    Score: 0.031
  19. Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2019 Oct; 26(10):3071-3079.
    View in: PubMed
    Score: 0.026
  20. Reply to 'A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18'. Breast. 2018 06; 39:148-149.
    View in: PubMed
    Score: 0.024
  21. Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy. Am J Clin Oncol. 2015 Jun; 38(3):242-7.
    View in: PubMed
    Score: 0.020
  22. Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1381-6.
    View in: PubMed
    Score: 0.016
  23. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer. 2011 Dec 15; 117(24):5476-84.
    View in: PubMed
    Score: 0.015
  24. Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy. Ann Surg Oncol. 2010 Nov; 17(11):2899-908.
    View in: PubMed
    Score: 0.014
  25. Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation. Ann Surg Oncol. 2009 Jun; 16(6):1606-11.
    View in: PubMed
    Score: 0.013
  26. Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center. Am J Surg. 2006 Oct; 192(4):541-4.
    View in: PubMed
    Score: 0.011
  27. Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results. Clin Breast Cancer. 2003 Dec; 4(5):348-53.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.